Seer (SEER) Retained Earnings (2020 - 2026)
Seer (SEER) posted quarterly Retained Earnings of -$482.8 million for Q1 2026, down 17.1% year-over-year from -$582.4 million in Q1 2025, and down 105287.15% quarter-over-quarter from $459000.0 in Q4 2025.
Seer (SEER) Retained Earnings (2020 - 2026) Analysis & Trends
Seer's Retained Earnings history runs 7 years deep, the most recent figure standing at -$482.8 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 17.1% year-over-year to -$482.8 million; the TTM figure through Mar 2026 stood at -$482.8 million (down 17.1% YoY), while the FY2025 annual figure was $459000.0, up 237.5% from the prior year.
- Retained Earnings for Q1 2026 stood at -$482.8 million, down from $459000.0 in the prior quarter.
- The five-year high for Retained Earnings was $710.5 million in Q1 2024, with the low at -$482.8 million in Q1 2026.
- The 5-year median for Retained Earnings is -$243.5 million (2023), against an average of -$86.0 million.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings jumped 989.78% in 2022, then slumped 158.03% in 2025.
- Seer's Retained Earnings stood at -$1.3 million in 2022, then surged by 84.65% to -$192000.0 in 2023, then jumped by 170.83% to $136000.0 in 2024, then jumped by 237.5% to $459000.0 in 2025, then sank by 105287.15% to -$482.8 million in 2026.
- Business Quant data shows SEER's Retained Earnings at -$482.8 million in Q1 2026, $459000.0 in Q4 2025, and -$450.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | 725.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 725.72 Mn |
| Mar 31, 2026 | -482.81 Mn |
| Dec 31, 2025 | 459,000.00 |
| Sep 30, 2025 | -449.98 Mn |
| Jun 30, 2025 | -431.70 Mn |
| Mar 31, 2025 | -412.32 Mn |
| Dec 31, 2024 | 136,000.00 |
| Sep 30, 2024 | -370.60 Mn |
| Jun 30, 2024 | -349.30 Mn |
| Mar 31, 2024 | 710.53 Mn |
| Dec 31, 2023 | -192,000.00 |
| Sep 30, 2023 | -288.00 Mn |
| Jun 30, 2023 | -266.90 Mn |
| Mar 31, 2023 | -243.50 Mn |
| Dec 31, 2022 | -1.25 Mn |
| Sep 30, 2022 | 657.43 Mn |
| Jun 30, 2022 | -173.00 Mn |
| Mar 31, 2022 | 638.86 Mn |
| Dec 31, 2021 | -536,000.00 |
| Sep 30, 2021 | -106.80 Mn |